These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35926164)

  • 1. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
    Sinnberg T; Lichtensteiger C; Ali OH; Pop OT; Jochum AK; Risch L; Brugger SD; Velic A; Bomze D; Kohler P; Vernazza P; Albrich WC; Kahlert CR; Abdou MT; Wyss N; Hofmeister K; Niessner H; Zinner C; Gilardi M; Tzankov A; Röcken M; Dulovic A; Shambat SM; Ruetalo N; Buehler PK; Scheier TC; Jochum W; Kern L; Henz S; Schneider T; Kuster GM; Lampart M; Siegemund M; Bingisser R; Schindler M; Schneiderhan-Marra N; Kalbacher H; McCoy KD; Spengler W; Brutsche MH; Maček B; Twerenbold R; Penninger JM; Matter MS; Flatz L
    Am J Respir Crit Care Med; 2023 Jan; 207(1):38-49. PubMed ID: 35926164
    [No Abstract]   [Full Text] [Related]  

  • 2. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis.
    Raymondos K; Leuwer M; Haslam PL; Vangerow B; Ensink M; Tschorn H; Schürmann W; Husstedt H; Rueckoldt H; Piepenbrock S
    Crit Care Med; 1999 Jan; 27(1):82-9. PubMed ID: 9934898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease.
    Dargaville PA; South M; McDougall PN
    Am J Respir Crit Care Med; 1999 Sep; 160(3):771-7. PubMed ID: 10471595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).
    Gommers D; Eijking EP; So KL; van't Veen A; Lachmann B
    Intensive Care Med; 1998 May; 24(5):494-500. PubMed ID: 9660267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
    Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
    Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
    Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
    Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
    Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA
    Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion.
    van Zyl JM; Smith J; Hawtrey A
    Drug Des Devel Ther; 2013; 7():139-48. PubMed ID: 23507973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant from diving aquatic mammals.
    Spragg RG; Ponganis PJ; Marsh JJ; Rau GA; Bernhard W
    J Appl Physiol (1985); 2004 May; 96(5):1626-32. PubMed ID: 14688033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
    Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of surfactant function in acute lung injury and early recovery.
    Mora R; Arold S; Marzan Y; Suki B; Ingenito EP
    Am J Physiol Lung Cell Mol Physiol; 2000 Aug; 279(2):L342-9. PubMed ID: 10926558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy.
    Haslam PL; Baker CS; Hughes DA; MacNaughton PD; Moat NE; Dewar A; Aggarwal A; Evans TW
    Int J Exp Pathol; 1997 Aug; 78(4):277-89. PubMed ID: 9505939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke.
    Subramaniam S; Whitsett JA; Hull W; Gairola CG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):274-80. PubMed ID: 8887443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
    McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
    Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant in birds: coping with surface tension in a tubular lung.
    Bernhard W; Gebert A; Vieten G; Rau GA; Hohlfeld JM; Postle AD; Freihorst J
    Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R327-37. PubMed ID: 11404309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia.
    Vanderzwan J; McCaig L; Mehta S; Joseph M; Whitsett J; McCormack DG; Lewis JF
    Eur Respir J; 1998 Dec; 12(6):1388-96. PubMed ID: 9877497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.
    Honda Y; Takahashi H; Shijubo N; Kuroki Y; Akino T
    Chest; 1993 Feb; 103(2):496-9. PubMed ID: 8432143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein-A in bronchoalveolar lavage fluid from neonates with RDS on conventional and high-frequency oscillatory ventilation.
    Gerdes JS; Abbasi S; Karp K; Hull W; Whitsett JA
    Pediatr Pulmonol; 1990; 9(3):166-9. PubMed ID: 2277737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.